CPI-17 Rabbit Polyclonal Antibody
To Order Now: info@attr-meeting.com
![]() |
|||
ABP57045-01ml | Abbkine | 0.1ml | EUR 289 |
|
|||
Description: A polyclonal antibody for detection of CPI-17 from Human, Mouse, Rat. This CPI-17 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human CPI-17 around the non-phosphorylation site of T38 |
![]() |
|||
ABP57045-02ml | Abbkine | 0.2ml | EUR 414 |
|
|||
Description: A polyclonal antibody for detection of CPI-17 from Human, Mouse, Rat. This CPI-17 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human CPI-17 around the non-phosphorylation site of T38 |
![]() |
|||
ES8044-100ul | ELK Biotech | 100ul | EUR 279 |
Description: A Rabbit Polyclonal antibody against CPI-17 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA |
![]() |
|||
ES8044-50ul | ELK Biotech | 50ul | EUR 207 |
Description: A Rabbit Polyclonal antibody against CPI-17 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA |
![]() |
|||
ABP57044-003ml | Abbkine | 0.03ml | EUR 158 |
|
|||
Description: A polyclonal antibody for detection of CPI-17 phospho Thr38) from Human, Mouse, Rat. This CPI-17 phospho Thr38) antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human CPI-17 around the phosphorylation site of T38 |
![]() |
|||
ABP57044-01ml | Abbkine | 0.1ml | EUR 289 |
|
|||
Description: A polyclonal antibody for detection of CPI-17 phospho Thr38) from Human, Mouse, Rat. This CPI-17 phospho Thr38) antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human CPI-17 around the phosphorylation site of T38 |
![]() |
|||
ABP57044-02ml | Abbkine | 0.2ml | EUR 414 |
|
|||
Description: A polyclonal antibody for detection of CPI-17 phospho Thr38) from Human, Mouse, Rat. This CPI-17 phospho Thr38) antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human CPI-17 around the phosphorylation site of T38 |
![]() |
|||
ES8043-100ul | ELK Biotech | 100ul | EUR 279 |
Description: A Rabbit Polyclonal antibody against CPI-17 (phospho Thr38) from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
![]() |
|||
ES8043-50ul | ELK Biotech | 50ul | EUR 207 |
Description: A Rabbit Polyclonal antibody against CPI-17 (phospho Thr38) from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
![]() |
|||
32203-05111 | AssayPro | 150 ug | EUR 261 |
![]() |
|||
STJ92448 | St John's Laboratory | 200 µl | EUR 197 |
Description: Rabbit polyclonal to CPI-17. |
![]() |
|||
32203-05121 | AssayPro | 150 ug | EUR 369 |
![]() |
|||
STJ90233 | St John's Laboratory | 200 µl | EUR 197 |
Description: Rabbit polyclonal to Phospho-CPI-17 (T38). |
![]() |
|||
32203-05141 | AssayPro | 150 ug | EUR 428 |
![]() |
|||
32203-05151 | AssayPro | 150 ug | EUR 428 |
![]() |
|||
32203-05161 | AssayPro | 150 ug | EUR 428 |
![]() |
|||
32203-05171 | AssayPro | 150 ug | EUR 471 |
![]() |
|||
APR15570G | Leading Biology | 0.1ml | EUR 528 |
Description: A Monoclonal antibody against Human CPI-17 alpha (N-term). The antibodies are raised in Rabbit and are from clone E305. This antibody is applicable in WB and IHC |
![]() |
|||
B1881-25 | Biovision | EUR 588 |
![]() |
|||
B1881-5 | Biovision | EUR 185 |
![]() |
|||
B1970-25 | Biovision | EUR 631 |
![]() |
|||
B1970-5 | Biovision | EUR 196 |
![]() |
|||
B2509-1 | Biovision | EUR 142 |
![]() |
|||
B2509-5 | Biovision | EUR 370 |
![]() |
|||
B4678-10 | ApexBio | 10 mg | EUR 270 |
Description: CPI-169 is a novel, small molecule and potent inhibitor of enhancer of zeste homolog 2 (EZH2) with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2) [1].CPI-169 has been found to be a potent EZH2 inhibitor with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2). |
![]() |
|||
B4678-100 | ApexBio | 100 mg | EUR 1442 |
Description: CPI-169 is a novel, small molecule and potent inhibitor of enhancer of zeste homolog 2 (EZH2) with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2) [1].CPI-169 has been found to be a potent EZH2 inhibitor with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2). |
![]() |
|||
B4678-5 | ApexBio | 5 mg | EUR 206 |
Description: CPI-169 is a novel, small molecule and potent inhibitor of enhancer of zeste homolog 2 (EZH2) with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2) [1].CPI-169 has been found to be a potent EZH2 inhibitor with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2). |
![]() |
|||
B4678-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 522 |
Description: CPI-169 is a novel, small molecule and potent inhibitor of enhancer of zeste homolog 2 (EZH2) with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2) [1].CPI-169 has been found to be a potent EZH2 inhibitor with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2). |
![]() |
|||
B4678-50 | ApexBio | 50 mg | EUR 856 |
Description: CPI-169 is a novel, small molecule and potent inhibitor of enhancer of zeste homolog 2 (EZH2) with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2) [1].CPI-169 has been found to be a potent EZH2 inhibitor with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2). |
![]() |
|||
B4836-1 | ApexBio | 1 mg | EUR 126 |
![]() |
|||
B4836-10 | ApexBio | 10 mg | EUR 534 |
![]() |
|||
B4836-5 | ApexBio | 5 mg | EUR 312 |
![]() |
|||
B1081-1 | ApexBio | 1 mg | EUR 128 |
Description: CPI-203 is a potent, selectivie and competitive small molecule inhibitor of BET bromodomain with a mean GI50 value of 0.23?M in MCL cell lines [1].As an inhibitor of BET proteins, CPI-203 inhibits BRD4 in vitro and in cells. |
![]() |
|||
B1081-5 | ApexBio | 5 mg | EUR 366 |
Description: CPI-203 is a potent, selectivie and competitive small molecule inhibitor of BET bromodomain with a mean GI50 value of 0.23?M in MCL cell lines [1].As an inhibitor of BET proteins, CPI-203 inhibits BRD4 in vitro and in cells. |
![]() |
|||
B1201-25 | Biovision | EUR 588 |
![]() |
|||
B1201-5 | Biovision | EUR 185 |
![]() |
|||
B6109-25 | ApexBio | 25 mg | EUR 496 |
Description: CPI-1189 is a proapoptotic cytokine tumor necrosis factor (TNF) alpha inhibitor.AIDS dementia complex is characterized by increased gliosis, apoptosis, and oxidative stress in the CNS, as well as a compromised blood-brain barrier. |
![]() |
|||
B6109-5 | ApexBio | 5 mg | EUR 171 |
Description: CPI-1189 is a proapoptotic cytokine tumor necrosis factor (TNF) alpha inhibitor.AIDS dementia complex is characterized by increased gliosis, apoptosis, and oxidative stress in the CNS, as well as a compromised blood-brain barrier. |
![]() |
|||
9404-1 | Biovision | EUR 131 |
![]() |
|||
9404-5 | Biovision | EUR 370 |
![]() |
|||
9464-10 | Biovision | EUR 142 |
![]() |
|||
9464-50 | Biovision | EUR 414 |
![]() |
|||
B7801-10 | ApexBio | 10 mg | EUR 168 |
Description: IC50: 0.03 and 11.0 ?M for CBP/EP300 and BRD4, respectively.CPI-637 is a CBP/EP300 bromodomain inhibitor. |
![]() |
|||
B7801-50 | ApexBio | 50 mg | EUR 453 |
Description: IC50: 0.03 and 11.0 ?M for CBP/EP300 and BRD4, respectively.CPI-637 is a CBP/EP300 bromodomain inhibitor. |
![]() |
|||
B7811-25 | ApexBio | 25 mg | EUR 453 |
Description: IC50: 10 nMCPI-455 is a KDM5 inhibitor.The KDM5 family of histone demethylases catalyzes the demethylation of histone H3 on lysine 4 (H3K4) and is required for the survival of drug-tolerant persister cancer cells (DTPs). |
![]() |
|||
B7811-5 | ApexBio | 5 mg | EUR 168 |
Description: IC50: 10 nMCPI-455 is a KDM5 inhibitor.The KDM5 family of histone demethylases catalyzes the demethylation of histone H3 on lysine 4 (H3K4) and is required for the survival of drug-tolerant persister cancer cells (DTPs). |
![]() |
|||
B7819-10 | ApexBio | 10 mg | EUR 440 |
Description: 0.002 ?M for biochemical IC50; 0.032 ?M for cellular EC50. CPI-1205 is an EZH2 inhibitor.Polycomb repressive complex 2 (PRC2) plays a key role in transcriptional silencing partially by installing methylation marks on lysine 27 of histone 3. |
![]() |
|||
B7819-25 | ApexBio | 25 mg | EUR 902 |
Description: 0.002 ?M for biochemical IC50; 0.032 ?M for cellular EC50. CPI-1205 is an EZH2 inhibitor.Polycomb repressive complex 2 (PRC2) plays a key role in transcriptional silencing partially by installing methylation marks on lysine 27 of histone 3. |
![]() |
|||
B7819-5 | ApexBio | 5 mg | EUR 270 |
Description: 0.002 ?M for biochemical IC50; 0.032 ?M for cellular EC50. CPI-1205 is an EZH2 inhibitor.Polycomb repressive complex 2 (PRC2) plays a key role in transcriptional silencing partially by installing methylation marks on lysine 27 of histone 3. |
![]() |
|||
A4333-10 | ApexBio | 10 mg | EUR 125 |
Description: CPI-613 is a first-in-class anti-cancer agent [1].CPI-613 is developed to target the pyruvate dehydrogenase complex which is a key mitochondrial enzyme of anaerobic glycolysis in tumor cells. |
![]() |
|||
A4333-100 | ApexBio | 100 mg | EUR 258 |
Description: CPI-613 is a first-in-class anti-cancer agent [1].CPI-613 is developed to target the pyruvate dehydrogenase complex which is a key mitochondrial enzyme of anaerobic glycolysis in tumor cells. |
![]() |
|||
A4333-5 | ApexBio | 5 mg | EUR 108 |
Description: CPI-613 is a first-in-class anti-cancer agent [1].CPI-613 is developed to target the pyruvate dehydrogenase complex which is a key mitochondrial enzyme of anaerobic glycolysis in tumor cells. |
![]() |
|||
A4333-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 119 |
Description: CPI-613 is a first-in-class anti-cancer agent [1].CPI-613 is developed to target the pyruvate dehydrogenase complex which is a key mitochondrial enzyme of anaerobic glycolysis in tumor cells. |
![]() |
|||
A4333-50 | ApexBio | 50 mg | EUR 212 |
Description: CPI-613 is a first-in-class anti-cancer agent [1].CPI-613 is developed to target the pyruvate dehydrogenase complex which is a key mitochondrial enzyme of anaerobic glycolysis in tumor cells. |
![]() |
|||
HY-100421 | MedChemExpress | 5mg | EUR 173 |
![]() |
|||
HY-100482 | MedChemExpress | 100mg | EUR 1042 |
![]() |
|||
HY-12863 | MedChemExpress | 10mM/1mL | EUR 163 |
![]() |
|||
HY-15846 | MedChemExpress | 2mg | EUR 133 |
![]() |
|||
HY-15955 | MedChemExpress | 100mg | EUR 2391 |